Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
39.43
-0.05 (-0.13%)
At close: May 19, 2026, 4:00 PM EDT
39.11
-0.32 (-0.81%)
After-hours: May 19, 2026, 6:57 PM EDT

TG Therapeutics Revenue

TG Therapeutics had revenue of $204.92M in the quarter ending March 31, 2026, with 69.56% growth. This brings the company's revenue in the last twelve months to $700.35M, up 81.26% year-over-year. In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth.

Revenue (ttm)
$700.35M
Revenue Growth
+81.26%
P/S Ratio
7.98
Revenue / Employee
$1,755,261
Employees
399
Market Cap
5.59B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025616.29M287.28M87.32%
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018152.00K--
Dec 31, 2017152.00K--
Dec 31, 2016152.00K-381.00-0.25%
Dec 31, 2015152.38K--
Dec 31, 2014152.38K--
Dec 31, 2013152.38K133.33K699.98%
Dec 31, 201219.05K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics827.11M
Corcept Therapeutics769.10M
Mirum Pharmaceuticals569.61M
Rhythm Pharmaceuticals217.17M
Xenon Pharmaceuticals7.50M
CG Oncology5.07M
Revenue Rankings

TGTX News

More News